Transom Acquires Binswanger Glass, Accelerating Next Phase of Growth for Leading U.S. Glazing Company Acquisition brings new investment and operational resources to fuel Binswanger Glass's expansion and service excellence, building on its 150-year legacy GlobeNewswire November 12, 2025 LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — Transom Capital Group (“Transom”), a Los Angeles-based private equity […]

Climb Channel Solutions Announces Strategic Partnership with Liongard GlobeNewswire November 12, 2025 EATONTOWN, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to announce a strategic partnership with Liongard, a leader in asset intelligence and automation.

Destination XL Group, Inc. to Announce Third Quarter 2025 Financial Results on Thursday, December 4, 2025 Company to Webcast Conference Call Live at 9:00 a.m. ET GlobeNewswire November 12, 2025 CANTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men's clothing

PayCargo and IBS Software Strengthen Long-Term Collaboration to Advance Air Cargo Long-term partners set new standard for digital infrastructure powering the future of air cargo GlobeNewswire November 12, 2025 CORAL GABLES, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) — PayCargo, the trusted logistics payment platform, and IBS Software, a leading SaaS solutions provider to the travel

Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests Supporting the Metrix(R) Molecular Point-of-Care Assay GlobeNewswire November 12, 2025 MISSISSAUGA, Ontario, Nov. 12, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, and SEKISUI Diagnostics, LLC (SEKISUI), a global manufacturer of innovative diagnostic tests, reagents,

Apellis Announces 5-Year GALE Data Showing SYFOVRE(R) (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years GlobeNewswire November 12, 2025 WALTHAM, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with SYFOVRE(R)

Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference GlobeNewswire November 12, 2025 CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat during the 2025 Jefferies London Healthcare Conference on

GlobalFoundries Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 MALTA, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) — GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the third quarter ended September 30, 2025. Key Third Quarter Financial Highlights Revenue of $1.688 billion Gross margin of 24.8% and Non-IFRS gross margin(1) of

AlphaTON's Cyncado Therapeutics and Australia's ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans ADDRI-sponsored trial in Australia planned to enroll approximately 50 patients, led by A/Prof Steven Kao and Dr Melvin Chin; part of Cyncado's international program for mesothelioma GlobeNewswire November 12, 2025 Dover, DE and Sydney, Australia, Nov. 12, 2025

OTC Markets Group Welcomes District Metals Corp. to OTCQX GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced District Metals Corp. (TSX-V: DMX; OTCQX: DMXCF), a disciplined, science-based exploration and development company, has